Skip to content

Bronchogen

Synthetic lung/bronchial bioregulator. Studied for respiratory function improvement and pulmonary tissue support. Sequence: Ala-Glu-Asp-Leu.

Intelligence Profile

Safety Profile

Evidence Limitations: The safety profile for Bronchogen is based on extremely limited clinical evidence. Only one completed clinical trial was identified (NCT00746759), but no safety data from this study is available in the provided evidence. Most available research consists of preclinical animal studies, primarily in rats.

Known Side Effects

Insufficient Evidence: No human clinical safety data is available in the provided literature. The preclinical studies examining Bronchogen's effects on bronchial epithelium and lung pathology in animal models do not report specific adverse effects or safety concerns, but this does not establish safety in humans.

Contraindications

Unknown: No contraindications have been established due to lack of adequate clinical safety data.

Drug Interactions

Insufficient Data: No drug interaction studies are available in the provided evidence. The mechanism of action appears to involve DNA interaction and cellular regulation based on preclinical studies, but potential interactions with other medications have not been investigated.

Populations That Should Avoid Use

Insufficient Safety Data: Without adequate human clinical trial data, safety cannot be established for any population, including:

  • Pregnant or breastfeeding women
  • Children and adolescents
  • Elderly patients
  • Patients with compromised immune systems
  • Patients with existing respiratory conditions

Clinical Considerations

The available research is primarily limited to:

  • Laboratory studies on peptide-DNA interactions
  • Animal studies in rats with induced lung pathology
  • One completed but unpublished clinical trial

Important Safety Disclaimer: This safety assessment is severely limited by the lack of comprehensive human clinical trial data. Healthcare providers should exercise extreme caution and thoroughly evaluate the risk-benefit ratio before considering any use of Bronchogen, as standard safety parameters have not been established through adequate clinical testing.

This information is for educational purposes only and does not constitute medical advice. Consult with a qualified healthcare provider for personalized medical guidance.

Free account required

Safety profile requires a free AXIFI account to access clinical data, safety profiles, and research papers.